You are here: Industry Insights > TTS

News List

CDC Panel Advises That Other Vaccines Be Preferred Over J&J Shot Drugs
December 17, 2021
Following continued reports of a rare but life-threatening clotting condition linked to the Johnson & Johnson coronavirus vaccine, a federal advisory panel on Thursday recommended that the Pfizer/BioNTech...
Vaxzevria and mRNA COVID-19 Vaccines Show Similar Safety Profiles americanpharmaceuticalreview
July 29, 2021
In a large real-world study, data published as a pre-print on The Lancet server from over one million individuals assessed the incidence rates of blood clotting disorders of thromboembolism and thrombocytopenia, including the very rare thrombosis with ...
Australia recommends AstraZeneca Covid-19 vaccine for people over 60 pharmaceutical-technology
June 18, 2021
The Australian Technical Advisory Group on Immunisation (ATAGI) has recommended the use of the AstraZeneca Covid-19 vaccine in Australia for individuals aged above 60 years.
TurtleTree Scientific and JSBiosciences enter into a strategic partnership for the development of cell culture media and contract manufacturing services prnasia
March 30, 2021
JSBiosciences has just announced a partnership with TurtleTree Scientific. Both parties have signed a letter of intent to collaborate in the development of cell culture media at a commercial scale.
Prevalence of Malignancy High in Takotsubo Syndrome Patients drugs
July 18, 2019
Overall, 16.6 percent of patients with takotsubo syndrome (TTS) have malignancy, and long-term mortality is higher in patients with malignancy...